ACTA1 and melanoma: Platel et al. (2022) [31] treated HUVECs with CM from SK-MEL-28 melanoma cells and observed reduced tube formation (capillary length), increased motility, enhanced actin stress fibers, and—by flow cytometry—an increased proportion of vWF+/α-SMA+ double-positive cells, supporting partial EndMT.